Nuvectis Pharma, Inc. (NASDAQ:NVCT) insiders seem bullish, own 58% and have been buying more recently
yahoo.com
news
2022-10-17 16:01:33

To get a sense of who is truly in control of Nuvectis Pharma, Inc. (NASDAQ:NVCT), it is important to understand the ownership structure of the business. We can see that individual insiders own the lion's share in the company with 58% ownership. Put another way, the group faces the maximum upside potential (or downside risk).

It's interesting to note that insiders have been buying shares recently. This might indicate that they expect share prices to rise in the near future.

Let's take a closer look to see what the different types of shareholders can tell us about Nuvectis Pharma.
